Konrad Dobschuetz

Konrad Dobschuetz, German-born, dual British national is a recognised global HealthTech leader. He can provide over 20 years of commercial innovation expertise from founding his own business to working for multinationals. In healthcare, Konrad is focused on the commercial adoption of impactful digital innovations contributing to positive patient and societal outcomes. In his work with key health system and industry leaders, he zooms in on emerging tech such as AI in diagnostics, pathway management and risk prediction. In his former role as National Director in the NHS Innovation Accelerator, its solutions reached over 3 million patients annual by the end of 2023. Konrad also worked for life sciences companies such as Novartis and Pfizer, driving large-scale digital transformation initiatives across a range of markets and implementing innovations for example to identify future patient needs using AI prediction. Over the years, connections have been established to various senior governmental stakeholders in the Departments of Health and Social Care, Business and Trade as well as NHS England on a national and local level. He also brings in relationships with leading LifeSciences companies such as AstraZeneca, Janssen, and Sanofi. Konrad is a frequent speaker at major conferences advocating for the equity of access to AI-augmented services and more collaboration between LifeSciences, the public sector, private investment and tech; a space he comfortably navigates within.